Biden ready to meet with COVID-19 team and provide comment

“At the briefing, the President will hear about the latest resources and personnel being sent to states and local communities to help with staffing needs and hospital capacity COVID-19 treatment. He will also hear from doctors about the latest data on the Omron version. While cases continue to rise, Americans who are fully vaccinated and infected are unlikely to have severe symptoms,” an official told CNN on Monday night.

“In brief remarks, the president will address the American people on these updates, as well as the importance of continuing to use the tools we know protect the American people — vaccines, boosters and masking.”

The Omicron variant caused 95.4% of new Covid-19 cases in the US last week, according to estimates posted by the US Centers for Disease Control and Prevention on Tuesday – significantly higher than the previous week.
Biden and his team have yet to reveal broad details about a key part of a plan announced last month to tackle COVID-19 this winter – an initiative to distribute half a billion tests for free using a website. .
An official said that the administration is still in the procurement process. Health experts have warned that a nationwide shortage of rapid home tests is coming during a critical period for testing as the Omron version disrupts daily life.

Meanwhile, the CDC is expected to update its guidance on recommended isolation periods, according to a source familiar with the plan, with the agency facing pressure to include a test component in its new shorter isolation period.
Earlier on Tuesday, the CDC also endorsed two major decisions by the US Food and Drug Administration.

The CDC followed the FDA’s recommendation to reduce the time required to complete the initial series of Pfizer/BioNTech Covid-19 and its calls to authorize a third dose, along with a booster shot from six months to five months. declared support. Primary vaccine series for certain immunized children aged 5 to 11 years.

In the same announcement Monday, the FDA authorized the expansion of booster eligibility for teens ages 12 to 15.


Source link

What Do You Think About this News